Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ernexa Therapeutics Inc. Director's Dealing 2016

Nov 7, 2016

35259_dirs_2016-11-07_358753b0-1c52-4aec-8ece-bee4fe34fc9c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NTN BUZZTIME INC (NTN)
CIK: 0000748592
Period of Report: 2016-11-04

Reporting Person: Wolff Allen (CFO and EVP)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-11-04 Common Stock A 26000 $6.64 Acquired 27910 Direct
2016-11-04 Common Stock A 1750 $6.64 Acquired 29660 Indirect
2016-11-04 Common Stock A 1750 $6.64 Acquired 31410 Indirect

Footnotes

F1: As custodian of Minor Child 1.

F2: As custodian of Minor Child 2.